Mental Health News

Medindia's Press Release’ section provides the latest press release on Mental Health from across the world for the global audience. This page links to 2472 Mental Health press releases.

Researchers from Wayne State University, University of Michigan, Harvard and UCLA Report Too Few Americans with Major Depressive Disorder Receive Adequate Care

More receive psychotherapy than medication: Study provides new detail on disparities DETROIT , Jan. 5 /PRNewswire-USNewswire/ -- Only about half of Americans diagnosed with major depression in a given year receive treatment for it and ...

Dainippon Sumitomo Pharma America Announces the NDA Submission of Lurasidone to the FDA for the Treatment of Schizophrenia

FORT LEE, N.J., Jan. 4 Dainippon Sumitomo Pharma America, Inc. (DSPA), a U.S. subsidiary of Dainippon Sumitomo Pharma Co., Ltd. (DSP), submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for lurasidone, an ...

Botulinum Toxins Such as Botox and Dysport May Offer Price Effective Treatments for Depression

WEST PALM BEACH, Fla. , Jan. 4 -- According to an article in the January 2010 edition of Drugs In Dermatology (abstract available at http:jddonline.com ), the use of botulinum type A toxins such as Botox and Dysport may offer a cost ...

Reportlinker Adds Alzheimer's Disease Therapeutics and Diagnostics: Global Markets

CONTACT: Nicolas Bombourg Reportlinker Email: [email protected] US: (805)652-2626 Intl: +1 805-652-2626 ...

Hyperbaric Oxygen Study Shows Potential Benefit for Patients With Traumatic Brain Injury

MINNEAPOLIS, Jan. 4 A 5-year study of patients with severe traumatic brain injury conducted at Hennepin County Medical Center in Minneapolis shows significant benefit of hyperbaric oxygen therapy to improve brain metabolism and its ability ...

Expert Panel Reaches Consensus on Our Ability to Improve Cognitive Health

BOSTON, Dec. 29 A panel of experts from leading northeastern universities recently reached consensus that proper nutrition, regular physical and mental activity, and adequate sleep can help to maintain and even improve cognitive skills in healthy ...

Intra-Cellular Therapies Announces the Results of a Phase I PET Study for ITI-007 for the Treatment of Schizophrenia and Other Psychiatric Disorders

NEW YORK, Dec. 21 Intra-Cellular Therapies, Inc. (ITI) announced at a recent conference on neuropsychiatric diseases the results from a recently completed Phase I clinical study demonstrating ITI-007, the Company's lead antipsychotic ...

FDA Approves Lilly's ZYPREXA(R) RELPREVV(TM) for Treatment of Schizophrenia in Adults

INDIANAPOLIS, Dec. 17 The U.S. Food and Drug Administration (FDA) approved ZYPREXA RELPREVV (olanzapine) For Extended Release Injectable Suspension for the treatment of schizophrenia in adults, Eli Lilly and Company (NYSE: LLY) ...

Naurex Inc. Initiates Phase I Clinical Trial of its Novel Mechanism NMDA Modulator GLYX-13 in Treatment-Resistant Depression

EVANSTON, Ill., Dec. 16 Naurex Inc., a new clinical stage company developing innovative treatments for depression and other CNS disorders based on its novel GFPA NMDA receptor modulators, today announced that it has initiated a Phase I ...

Naurex Inc. Announces Presentation of Preclinical Data Showing its Novel Mechanism NMDA Modulator Exhibits Robust and Rapid-Onset Antidepressant Activity With No Signs of Classic NMDA-Associated Side Effects